DarioHealth Corp. announced on May 8, 2025, new research published in the Journal of Medical Internet Research (JMIR), demonstrating the effectiveness of its personalized digital health interventions. The study focused on driving flu vaccine awareness among Dario members living with diabetes, a high-risk population. This research highlights the value of tailored messaging in improving health outcomes.
The pragmatic randomized follow-up study involved a large dataset of 64,904 members. It compared the impact of a monthly flu vaccination campaign with an adapted version featuring more personalized and frequent messages, against a control group. The results showed that the group receiving personalized and frequent messages demonstrated significantly improved awareness of flu risks and higher vaccination rates.
Yifat Hershcovitz, PhD, VP of Clinical and Scientific Affairs at Dario, stated that the study validates how Dario's personalization engine can deliver measurable clinical impact. Dr. Omar Manejwala, Chief Medical Officer, emphasized that this research adds to the evidence showing how Dario's solutions can drive real clinical outcomes through digital innovation.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.